DAX
18.255,60 +92,08 (+0,51%) Euro Stoxx 50
4.938,45 +31,15 (+0,63%) Dow Jones 30
39.150,33 +15,53 (+0,04%) Gold
2.339,20 +8,00 (+0,34%) EUR/USD
1,0741 +0,0044 (+0,41%) Bitcoin EUR
56.888,24 -3.070,90 (-5,12%)
OptiBiotix Health Plc (OB3.F)
OptiBiotix Health Plc
Innovation Centre
Innovation Way Heslington
York YO10 5DG
United Kingdom
https://www.optibiotix.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 9
Beschreibung
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia, and diabetes. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.
Corporate Governance
OptiBiotix Health Plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.
